Delivery Order SPE2DB22D2211-SPE2DB25FRQEF

Award Date 1/31/25
Potential Completion Date 2/3/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Potassium Chloride (10% 40MEQ/30ML) cups in a 30ML size. The $1,807.11 fixed-price contract was awarded by the Defense Logistics Agency (DLA) on December 10, 2024, with a completion date of December 11, 2024. This delivery order is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 100ml solutions of 10 milliequivalents per 100ml potassium chloride. The contract has a firm fixed price of $1,549.73 and an ultimate completion date of December 2, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,192.10 for the supply of potassium chloride 10 MEQ/100 mL solution. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 26, 2024. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of a pharmaceutical product - Potassium Chloride 20 MEQ/10 ML Concentrate in 10 ML vials. The award, with a ceiling value of $1,259.78, has a performance period through March 22, 2024. The delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of potassium chloride medication, priced at a firm fixed price of $2,130.60, with a period of performance through May 30, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers the delivery of potassium chloride extended-release capsules, a critical medication for various medical conditions. The contract has a ceiling value of $3,641.65 and a completion date of September 16, 2024. There is no set-aside designation...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $3,030.52 order is for the supply of 4,564,042,888 potassium chloride extended-release tablets in 100-count bottles. This delivery order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp as the prime contractor to...
This firm fixed price delivery order, valued at $1,064.32, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract is for the supply of potassium chloride injection, a pharmaceutical product used for medical treatment. This delivery order is part of Amerisourcebergen's broader indefinite delivery contract with DLA to provide pharmaceuticals and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,224.00 firm fixed-price delivery order is for the supply of potassium chloride solution, a critical medical product used to treat various medical conditions. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), is for the delivery of 4,564,822 units of potassium chloride extended-release capsules. The firm-fixed-price contract has a ceiling value of $1,071.90 and a completion date of June 7, 2024. This contract is not associated with a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRQEF
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of potassium chloride medication in 15 mL cups. The contract has a ceiling value of $2,189.27 and a completion date of February 3, 2025. It is a firm fixed-price contract type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order does not have a set-aside designation, indicating open competition.

Generated 5/4/25, 12:47 AM